The last 12 months in the cannabis industry offered plenty of hype and headlines.
Voters and lawmakers in a handful of additional states and countries said “yes” to recreational use and medical marijuana. President Joe Biden made history by signing a marijuana research bill into law. More celebrities jumped into business ventures featuring the previously taboo product. Law firms expanded their cannabis practices or dived into psychedelics law.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
